Cyclin‐dependent kinase inhibitor 1A, golgin A7 family member B and transforming growth factor B1‐induced anti‐apoptotic factor 1 (TIAF1) had potential diagnostic value for discriminating ESCC patients with G1 from those with G3. Here, MYO18A is linked to esophageal squamous cell carcinoma.